| Muscle Cell News 4.23 July 8, 2019 | |
|
|
|
|
TOP STORYDynamic Genetic Regulation of Gene Expression during Cellular Differentiation Researchers mapped expression quantitative trait loci throughout differentiation to elucidate the dynamics of genetic effects on cell type-specific gene expression. They generated time-series RNA sequencing data, capturing 16 time points during the differentiation of induced pluripotent stem cells to cardiomyocytes, in 19 human cell lines. [Science] Abstract | Press Release |
|
|
|
|
PUBLICATIONS(Ranked by impact factor of the journal)CARDIAC MUSCLE CELLSDesigner Artificial Membrane Binding Proteins to Direct Stem Cells to the Myocardium The authors present a new cell membrane modification methodology where the inherent heart tissue homing properties of the infectious bacteria Streptococcus gordonii were transferred to human stem cells. This was achieved via the rational design of a chimeric protein-polymer surfactant cell membrane binding construct, comprising the cardiac fibronectin binding domain of the bacterial adhesin protein CshA fused to a supercharged protein. [Chem Sci] Full Article | Press Release Following apical resection of the neonatal mouse heart, scientists observed limited regeneration potential. Fate-mapping of Tbx18MerCreMer mice revealed that newly formed coronary vessels and a limited number of cardiomyocytes were derived from the T-box transcription factor 18 lineage. [Cell Rep] Full Article | Graphical Abstract Cardioprotective Role of APIP in Myocardial Infarction through ADORA2B Apaf-1-interacting protein (APIP) expression was significantly increased in primary neonatal cardiomyocytes under hypoxic conditions and this induction reduced myocardial cell death via the activation of the AKT-HIF1α pathway. Accordingly, infarct sizes of APIP transgenic mice after left anterior descending artery ligation were significantly reduced compared to those of wild-type mice. [Cell Death Dis] Full Article Inhibition of p38 MAPK by SB203580 blunted the ER stress intensified by C1q-tumor necrosis factor-related protein-3 (Ctrp3) deficiency. In vitro, CTRP3 protected neonatal rat cardiac myocytes against phenylephrine-induced cardiomyocyte hypertrophy. [Cell Death Dis] Full Article Myocardial Death and Dysfunction after Ischemia-Reperfusion Injury Require CaMKIIδ Oxidation Investigators found reduced myocardial death, and improved left ventricular function 24-hours after ischemia-reperfusion (I/R) injury in methionines with valines in vivo and in vitro compared to wild type controls. Loss of ATP sensitive K+ channel (KATP) current contributed to I/R injury, and Ca2+/calmodulin-dependent protein kinase II (CaMKII) promoted sequestration of KATP from myocardial cell membranes. [Sci Rep] Full Article SKELETAL MUSCLE CELLSAnalysis of C2C12 cell knockout for each casein kinase 2 (CK2) subunit revealed that: CK2β was mandatory for the expression of the muscle master regulator myogenic differentiation 1 in proliferating myoblasts, thus controlling both myogenic commitment and subsequent muscle-specific gene expression and myotube formation; and that CK2α was involved in the activation of the muscle-specific gene program. [FASEB J] Abstract Inhibition of Activin-Like Kinase 4/5 Attenuates Cancer Cachexia Associated Muscle Wasting Researchers investigated in vitro and in vivo the efficacy of ALK4/5 receptor blockers SB431542 and GW788388 in preventing muscle wasting, and explored synergy with IGF-I analogue LONG R3 (LR3) IGF-I. In vitro, C2C12 skeletal muscle cells were treated with vehicle, SB431542, GW788388 and LR3 IGF-I. [Sci Rep] Full Article Insulin-resistant skeletal muscle cells were prepared by treatment with an inhibitor of the insulin receptor, HNMPA-(AM)3 or palmitate, and Zip7 was analyzed along with pAkt, pTyrosine and Glut4. Similarly, mice fed normal chow or a high-fat diet were also analyzed for protein expression of Glut4 and Zip7. [Cells] Full Article SMOOTH MUSCLE CELLSResearchers investigated the roles of thioredoxin (Trx)1 and Trx reductase1 proteins in regulation of cell growth, death, reactive oxygen species and glutathione levels in hydrogen peroxide (H2O2)-treated human pulmonary artery smooth muscle (HPASM) cells. H2O2 induced growth inhibition and cell death in HPASM cells over 24 hours. [Toxicol In Vitro] Abstract The effects of curcumin and quercetin on human aortic smooth muscle cells (HaVSMCs) survival in the generation of molecular and cellular toxicity by irinotecan, folinic acid and 5-fluorouracil (FOLFIRI) treatment and the involvement of vital cellular signaling pathways were investigated. Scientists analysed both FOLFIRI toxicity and the therapeutic potential of quercetin and curcumin in terms of HaVSMC damage using molecular probe and florescence staining, random amplified polymorphic DNA, qRT-PCR and Western blot assays. [Cardiovasc Toxicol] Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & ESC & iPSC News. |
|
|
|
|
REVIEWSAlterations in epigenetic marks, including DNA methylation and histone modifications, are linked to the skeletal muscle transcriptional responses to exercise that ultimately mediate the exercise adaptations. [Trends Endocrinol Metab] Abstract Vascular Smooth Muscle Cells in Atherosclerosis The authors present the evidence for vascular smooth muscle cell (VSMC) plasticity and summarize the roles of VSMCs and VSMC-derived cells in atherosclerotic plaque development and progression. Correct attribution and spatiotemporal resolution of clinically beneficial and detrimental processes will underpin the success of any therapeutic intervention aimed at VSMCs and their derivatives. [Br J Pharmacol] Abstract Synthetic Scaffolds for Musculoskeletal Tissue Engineering: Cellular Responses to Fiber Parameters Investigators highlight the characteristics of fibrous ECM proteins and of fabrication methods for fibers and model systems used in musculoskeletal tissue engineering, with comparison to other tissues and cell-based systems where gaps in the literature were identified. They examine the relationship between the fiber parameters of tissue engineered scaffolds and the cell responses elicited. [NPJ Regen Med] Abstract Visit our reviews page to see a complete list of reviews in the muscle cell research field. |
|
|
|
|
SCIENCE NEWSCytokinetics Announces Preclinical Data for Reldesemtiv Presented Cytokinetics, Incorporated announced that data from two pre-clinical studies of reldesemtiv were presented showing that the addition of reldesemtiv to treatment with SMN upregulators significantly increased muscle force in a mouse model of spinal muscular atrophy. [Press release from Cytokinetics, Incorporated discussing research presented at the 2019 Annual Cure SMA Conference, Anaheim] Press Release Catabasis Pharmaceuticals Provides Update on Global Phase III PolarisDMD Trial for Edasalonexent Catabasis Pharmaceuticals, Inc. shared an update on the clinical development of edasalonexent, a novel NF-kB inhibitor for the treatment of Duchenne muscular dystrophy (DMD) this week. [Press release from Catabasis Pharmaceuticals, Inc. discussing research presented at the 25th Annual Parent Project Muscular Dystrophy (PPMD) Connect Conference, Orlando] Press Release FibroGen, Inc. announced that the company presented interim data on their open-label, single-arm Phase II trial evaluating pamrevlumab, a monoclonal antibody to connective tissue growth factor in non-ambulatory subjects with Duchenne muscular dystrophy. [Press release from FibroGen, Inc. discussing research presented at the 25th Annual Parent Project Muscular Dystrophy (PPMD) Connect Conference, Orlando] Press Release Biogen announced new results from the NURTURE study, adding data to the longest study of spinal muscular atrophy in pre-symptomatic infants. These data reported, after up to 45.1 months of analysis, continue to demonstrate efficacy and safety in patients treated pre-symptomatically with SPINRAZA in comparison to the natural history of this disease. [Press release from Biogen discussing research presented at the 2019 Annual Cure SMA Conference, Anaheim] Press Release Pfizer Inc. will present initial Phase Ib clinical data on PF-06939926, an investigational gene therapy to potentially treat DMD. These are preliminary data drawn from a small number of participants in an ongoing study. [Press release from Pfizer Inc. discussing research presented at the 25th Annual Parent Project Muscular Dystrophy (PPMD) Connect Conference, Orlando] Press Release |
|
|
|
|
INDUSTRY NEWSLigand Pharmaceuticals Incorporated and SQ Innovation AG announced that the two companies have entered into long-term, exclusive commercial license and supply agreements for use of Ligand’s Captisol® technology in the formulation of high-concentration furosemide for the treatment of edema in patients with heart failure. [Ligand Pharmaceuticals Incorporated (Business Wire, Inc.)] Press Release Resverlogix’s BETonMACE Phase III Epigenetics Trial Completes Final Safety Visits Resverlogix Corp. announced that all patients active in BETonMACE, the company’s event-based, Phase III registration trial, recently completed their final, follow-up safety visits, marking another important step towards trial completion. [Resverlogix Corp] Press Release | |
|
|
|
POLICY NEWSHungarian Government Takes Control of Research Institutes despite Outcry After months of struggle between Hungary’s research ministry and its scientific community, the nation’s parliament ratified a law on 2 July that gives the government control over the 40 or so institutes belonging to the Hungarian Academy of Sciences. The government says that its aim is to make research more innovative. [Nature News] Editorial Mexican President Eases Up on Researchers’ Travel Rules A month after announcing increased austerity measures on international travel for scientists, Mexico’s National Council of Science and Technology announced last month that at least one restriction would be loosened. Scientists would not require presidential approval for every trip abroad. [The Scientist] Editorial Mount Sinai Institute Director Facing Discrimination Allegations Leaves Post The director of the Arnhold Institute for Global Health, who is facing allegations of age and gender discrimination, is leaving that position, the dean of the Icahn School of Medicine at Mount Sinai announced in an email. [ScienceInsider] Editorial
|
|
EVENTSNEW Annual World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease Visit our events page to see a complete list of events in the community.
|
|
JOB OPPORTUNITIESNEW Technical Director – Stem Cell and Genomic Engineering (Icahn School of Medicine at Mount Sinai) NEW Postdoctoral Fellow – Cardiovascular Biology (Oklahoma Medical Research Foundation) Research Scientist – Cellular Electrophysiology (Duke University) Research Fellow – Genetically Inherited Cardiomyopathies (The University of Oxford) Postdoctoral Researcher – Muscle Atrophy and Metabolism (McGill University) Postdoctoral Researchers – Cardiovascular Studies (Virginia Tech) Postdoctoral – Proteomics of Muscles and Aging (Oklahoma Medical Research Foundation) Postdoctoral Fellow – Facioscapulohumeral Muscular Dystrophy Research (Pfizer)
Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
|
|
|
Have we missed an important article or publication in Muscle Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. |
|
|

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News


